VFA
FLNA

Virtus Fund Advisers’s Filana Therapeutics FLNA Stock Holding History

Virtus Fund Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-464
Closed -$19K – 1789
2014
Q2 		$19K Buy
+464
New +$17.2K ﹤0.01% 2470

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtus Fund Advisers's FLNA Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Filana Therapeutics (FLNA) in Q3 2014, closing a stake of 464 shares — an estimated $19K sold.

Virtus Fund Advisers first reported a position in FLNA in Q2 2014 and held it in 1 quarter. The position peaked at $19K in Q2 2014. 73 funds tracked by Wall St. Rank hold FLNA as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Filana Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 464 Filana Therapeutics shares in Q3 2014, an estimated $19K.
  • Virtus Fund Advisers first reported a position in Filana Therapeutics in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Filana Therapeutics position peaked at $19K in Q2 2014.
  • 73 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.